Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63DOUGLAS-JONES, A; SHAH, V; MORGAN, J et al.Histopathology. 2005, Vol 47, Num 2, pp 202-208, issn 0309-0167, 7 p.Article

The reactivity to CK5/6 antibody in tumor cells from non-small cell lung cancers shed into pleural effusions predicts survivalSAND DEJMEK, Janna; DEJMEK, Annika.Oncology reports. 2006, Vol 15, Num 3, pp 583-587, issn 1021-335X, 5 p.Article

If it's not CK5/6 positive, TTF-1 negative it's not a squamous cell carcinoma of lungDOWNEY, Paul; CUMMINS, Robert; MORAN, Margaret et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2008, Vol 116, Num 6, pp 526-529, issn 0903-4641, 4 p.Article

Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patientsSTEFANSSON, Ingunn M; SALVESEN, Helga B; AKSLEN, Lars A et al.International journal of cancer. 2006, Vol 118, Num 5, pp 1227-1233, issn 0020-7136, 7 p.Article

Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breastJONES, Chris; MERRETT, Samantha; THOMAS, Valerie A et al.Journal of pathology. 2003, Vol 199, Num 2, pp 152-156, issn 0022-3417, 5 p.Article

Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6MUKHOPADHYAY, Sanjay; KATZENSTEIN, Anna-Luise A.The American journal of surgical pathology. 2011, Vol 35, Num 1, pp 15-25, issn 0147-5185, 11 p.Article

The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotypeXIAO WANG; LAN CHAO; GUOHUI MA et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 2, pp 271-278, issn 0171-5216, 8 p.Article

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFRHICKS, David G; SHORT, Sarah M; TUBBS, Raymond R et al.The American journal of surgical pathology. 2006, Vol 30, Num 9, pp 1097-1104, issn 0147-5185, 8 p.Article

Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesionsMACGROGAN, G; ARNOULD, L; BECETTE, V et al.Histopathology. 2008, Vol 52, Num 6, pp 689-697, issn 0309-0167, 9 p.Article